ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Irish authorities recalled the rare disease drug Tavneos after reports of about 20 deaths linked to liver dysfunction in Japan since 2022.
Irish authorities recalled the rare disease drug Tavneos after reports of about 20 deaths linked to liver dysfunction in Japan since 2022.
Irish authorities recalled the rare disease drug Tavneos after reports of about 20 deaths linked to liver dysfunction in Japan since 2022.
Irish authorities recalled the rare disease drug Tavneos after reports of about 20 deaths linked to liver dysfunction in Japan since 2022.
Irish authorities recalled the rare disease drug Tavneos after reports of about 20 deaths linked to liver dysfunction in Japan since 2022.
Irish authorities recalled the rare disease drug Tavneos after reports of about 20 deaths linked to liver dysfunction in Japan since 2022.
Read More
The FDA approved Tauklarify, a tau PET imaging agent, for detecting tau pathology in adults evaluated for Alzheimer’s disease.
Read More
The FDA approved Glenmark’s generic Fluticasone Propionate Nasal Spray, equivalent to Flonase, for treating allergic rhinitis symptoms in the U.S.
Read MoreThe FDA approved Pluvicto with androgen receptor inhibitors for earlier-stage PSMA-positive metastatic hormone-sensitive prostate cancer, expanding patient eligibility.
Read MoreAlkem Laboratories and Major Pharmaceuticals recalled 299,520 dabigatran etexilate capsules nationwide due to FDA quality concerns.
Read MoreChipotle removed jalapeños from some Minnesota restaurants after a Salmonella Javiana outbreak sickened 110 people linked to the peppers.
Read MoreThe CDC is investigating over 7,400 suspected Cyclospora cases and a second outbreak cluster amid a record U.S. cyclosporiasis surge in 2026.
Read MoreMidwest Poultry Services recalled nearly 1.6 million dozen eggs from Texas farms due to potential Salmonella Enteritidis contamination risk.
Read MoreFourteen Americans returning from Congo were quarantined for four days at a New York military base due to Ebola outbreak precautions.
Read MoreViiV Healthcare presented Phase IIIb VOGUE trial data comparing two-drug Dovato to three-drug Biktarvy in treatment-naïve adults with HIV at AIDS 2026.
Read More
